Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128944 · ClinicalTrials.gov registry record
Feasibility Assessment of the Blood Pressure Imager, a Continuous Blood Pressure Monitor
A clinical trial, sponsored by Tufts University.
- Completed
- Registry status
- 100
- Enrollment target
NCT03128944: Completed study, sponsored by Tufts University.
NCT03128944 is a clinical trial that has completed, run by Tufts University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03128944 has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators are developing Blood Pressure Imager (BPI), which is a new technology that does not require cuffs or expensive equipment, and can be used by untrained individuals in underserved, low-resource environments at their own homes or regional care settings. Over the last one-year the investigators have developed the BPI prototype, which is ready for testing. BPI is a wrist device that includes a camera, color lights and soft membrane with a reflective coating. In this device feasibility study, the BPI will be placed over the radial artery at the wrist with the help of a wrist strap. The primary purpose of this feasibility study is to compare the BPI with a commercially available cuff-based blood pressure measuring devices.
Primary Outcome
Comparison of BPI measurements with reference blood pressure measurements with commercially available cuff-based blood pressure measuring device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-10-30 |
What the finished NCT03128944 record still lists
NCT03128944 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03128944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03128944 about?
NCT03128944 is a clinical study titled "Feasibility Assessment of the Blood Pressure Imager, a Continuous Blood Pressure Monitor". The investigators are developing Blood Pressure Imager (BPI), which is a new technology that does not require cuffs or expensive equipment, and can be used by untrained individuals in underserved, low-resource environments at their own homes or regional care settings. Over the last one-year the inve...
What is the current status of trial NCT03128944?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-05-01. Estimated completion is 2019-10-30.
Who is sponsoring clinical trial NCT03128944?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI